RIP
MIRM icon

Reliant Investment Partners’s Mirum Pharmaceuticals MIRM Stock Holding History

Reliant Investment Partners’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$552K Hold
5,975
– – 0.46% 52
2025
Q4 		$472K Sell
5,975
-1,000
-14% -$71.8K 0.37% 59
2025
Q3 		$509K Hold
6,975
– – 0.4% 56
2025
Q2 		$355K Hold
6,975
– – 0.31% 83
2025
Q1 		$314K Hold
6,975
– – 0.32% 73
2024
Q4 		$288K Buy
+6,975
New +$291K 0.26% 87

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Reliant Investment Partners's MIRM Position: Q1 2026 in Review

Reliant Investment Partners held its Mirum Pharmaceuticals (MIRM) position steady in Q1 2026 at 5,975 shares worth $552K. The position accounts for 0.46% of the portfolio, ranked #52.

Reliant Investment Partners first reported a position in MIRM in Q4 2024 and has held it in 6 quarters since. 311 funds tracked by Wall St. Rank hold MIRM as of Q1 2026.

  • Reliant Investment Partners held 5,975 shares of Mirum Pharmaceuticals worth $552K as of Q1 2026.
  • Reliant Investment Partners left its Mirum Pharmaceuticals share count unchanged in Q1 2026.
  • Mirum Pharmaceuticals made up 0.46% of Reliant Investment Partners's portfolio in Q1 2026, its #52 holding.
  • Reliant Investment Partners first reported a position in Mirum Pharmaceuticals in Q4 2024 and has held it in 6 quarters since.
  • 311 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q1 2026.

Based on Reliant Investment Partners's 13F filing for Q1 2026, filed 11 May 2026.